The future of clinical research lies in personalisation. Across fields like oncology, rare diseases, and immunotherapy, pharmaceutical companies and CROs are embracing precision medicine, developing treatments tailored to a patient’s genetic profile, biomarkers, and lifestyle. But delivering truly individualised care demands equally tailored infrastructure.
This is where Xolomon plays a critical role. Our advanced electronic Clinical Research Document (eCRD) platform is designed to support the complexity and data-intensity of personalised trials, helping research teams stay agile, compliant, and ahead of the curve.
Precision medicine needs precision data
Personalised studies often involve small, genetically stratified populations, complex inclusion criteria, and real-time decision-making based on biomarkers or adaptive designs. Traditional paper-based workflows and static EDC systems simply can’t handle this level of sophistication.
Xolomon’s eCRD technology offers the flexibility, scalability, and automation required to collect, validate, and manage diverse clinical data sets, serving as a foundation for successful precision trials.
Why Xolomon’s eCRD is ideal for personalised clinical research
1. Built to capture biomarker and genomic data
Xolomon allows sponsors and researchers to customise case report forms that accommodate mutation status, sequencing results, and other biomarker-driven fields, essential for targeted therapies and patient stratification.
2. Supports adaptive and real-time trial models
With real-time data capture and protocol flexibility, our platform enables researchers to implement rolling enrolment, adjust trial arms based on interim data, and accelerate recruitment without compromising data quality.
3. Longitudinal data collection made eas
Personalised treatments require ongoing tracking of patient outcomes, side effects, and biomarkers over time. Xolomon’s eCRD makes longitudinal monitoring straightforward and auditable, ensuring consistency across visits and sites.
4. Compliance-first architecture
Designed with GCP, EMA, and FDA requirements in mind, our system includes automated audit trails, access controls, and versioning, simplifying documentation for regulators and ethics committees.
5. Ideal for decentralised or hybrid trials
With remote participation becoming standard in many personalised studies, Xolomon’s cloud-based platform allows for secure remote data entry and centralised oversight, streamlining operations across all research sites.
Xolomon: making research accessible
As the life sciences industry shifts towards more personalised, data-driven approaches, technology providers must rise to the challenge. At Xolomon, we are committed to supporting researchers, sponsors and CROs in making precision medicine a scalable and sustainable reality.
Whether you’re planning a new biomarker-led trial, managing multiple rare disease cohorts, or integrating real-world data sources, Xolomon’s eCRD platform gives you the tools to collect and manage data intelligently, securely, and efficiently.
Personalised medicine is reshaping the way treatments are developed, and clinical trials must evolve in parallel. With Xolomon’s eCRD, you’re not just digitising forms; you’re laying the digital foundation for faster, smarter, and more responsive research.
